Cryo Cell International (CCEL) Shares Outstanding (Diluted Average) (2010 - 2020)

Cryo Cell International (CCEL) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $8.1 million in Q2 2020.

• Quarterly Shares Outstanding (Diluted Average) fell 3.68% year-over-year to $8.1 million in Q2 2020, while the trailing twelve-month figure through May 2020 was $8.1 million (down 3.68% YoY) and the FY2019 annual result came in at $8.4 million, up 12.72% from the prior year.
• Shares Outstanding (Diluted Average) was little changed at $8.1 million in Q2 2020 per CCEL's latest filing, from $8.1 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $8.4 million in Q3 2019 and bottomed at $7.5 million in Q4 2018.
• The 3-year median for Shares Outstanding (Diluted Average) is $8.4 million (2018), against an average of $8.2 million.
• The widest annual swing landed in 2019, when Shares Outstanding (Diluted Average) rose 12.72%; it then dropped 3.68% in 2020.
• Tracing CCEL's Shares Outstanding (Diluted Average) over 3 years: stood at $7.5 million in 2018, then climbed by 12.72% to $8.4 million in 2019, then retreated by 3.57% to $8.1 million in 2020.
• Per Business Quant, the three latest CCEL Shares Outstanding (Diluted Average) figures stand at $8.1 million (Q2 2020), $8.1 million (Q1 2020), and $8.4 million (Q4 2019).

Peer Comparison